Loading...

Clearmind Medicine Inc.

CMND•NASDAQ
Healthcare
Biotechnology
$0.83
$0.18(28.38%)
U.S. Market opens in 8h 16m

Clearmind Medicine Inc. (CMND) Stock Overview

Explore Clearmind Medicine Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap114K
P/E Ratio-0.12
EPS (TTM)$-24.12
ROE-2.12%
Fundamental Analysis

AI Price Forecasts

1 Month$0.95
3 Months$0.89
1 Year Target$1.49

CMND Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Clearmind Medicine Inc. (CMND) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.11, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.49.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.12 and a market capitalization of 114K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
28.38%
5-Day Change
-29.87%
1-Month Change
12.77%
3-Month Change
-66.62%
6-Month Change
-97.80%
Year-to-Date (YTD) Change
-53.90%
1-Year Change
-97.85%
3-Year Change
-99.88%
5-Year Change
-99.99%
All-Time (Max) Change
-99.99%

Contact Information

https://www.clearmindmedicine.com
604 260 1566
1220 West 6th Avenue, Vancouver, BC, V6H 1A5

Company Facts

4 Employees
IPO DateNov 15, 2022
CountryCA
Actively Trading

Frequently Asked Questions